Skip to main content
. 2017 Feb 28;23(8):1489–1496. doi: 10.3748/wjg.v23.i8.1489

Table 2.

Factors affecting the clinical activity of Crohn’s disease: Results of logistic regression analysis of each factor

IFX-TL (μg/mL) ATI levels (AU/mL)
Overall predictability (%) 82.0 75.9
Quiescent group (%) 82.9 96.3
Active group (%) 80.4 43.1
P value < 0.001 0.003
Odds ratio (95%CI) 0.103 (0.045-0.236) 1.055 (1.018-1.093)

IFX-TL: Infliximab trough level; ATI: Antibody to infliximab.